[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dermal Grafts Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 202 pages | ID: G94831730E8EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Dermal grafting is the procedure in which the part of the skin is replaced with the skin from other parts of the body. A dermal graft is used to replace damaged or missing skin or to provide a temporary wound covering. Dermal grafting is performed or recommended for skin infections, injury, deep burns, skin cancer, pressure ulcers and reconstructive surgeries. There are two types of skin grafts Viz. the split-level thickness and full thickness. Split-level thickness includes removal of dermal and epidermal layers of the skin and full-thickness grafts involve removal of muscles and blood vessels. Patients with deeper tissue loss need a full-thickness skin graft to cover the wound. This requires an entire thickness of skin from the donor site, not just the top two layers.

Dermal grafts market is driven by rise in the incidence of burns, accidents and surgeries requiring removal of skin. In addition factors such as skin loss due to cancer and infection are boosting the demand for dermal grafts. According to Skin Cancer Foundation, each year over 5.4 Mn cases of non-melanoma skin cancer are reported and over 3.3 Mn people are treated for the same in the U.S. Furthermore, technological advances in dermatomes such as electric and air dermatomes, increased accuracy and control by using exchangeable blades are the factors expected to bolster skin grafts market over the forecast period. However, complications of dermal grafts such as infection, pain, high cost of the procedure, and tissue rejection are some of the factors hindering the growth of the global dermal grafts market.

Dermal grafts market segmented on the basis of equipment, graft type, thickness, application, equipment and end-user

Based on equipment, skin grafts market is segmented into
  • Dermatomes
  • Knives Dermatomes
  • Electric Dermatomes
  • General Surgical Instruments
  • Consumables
  • Air Dermatomes
Based on graft type, dermal grafts market segmented into
  • Autologous
  • Isogenic
  • Allogeneic
  • Xenogeneic
  • Prosthetic
Based on thickness, dermal grafts market is segmented into
  • Split Thickness
  • Full Thickness
  • Composite Graft
Based on application, dermal grafts market is segmented into
  • Burns
  • Extensive Wound
  • Skin Cancer
  • Infection
  • Others
Based on end-user, dermal grafts market is segmented into
  • Hospitals
  • Dermatology Clinics
  • Ambulatory Surgical Centers
Considering the several factors that are impacting the growth of dermal grafts, the dermal grafts market is expected to grow at significant CAGR. According to WHO, over 96% of the fatal fire-related deaths have occurred in the low and middle-income countries whereas in the high-income countries have less likely deaths due to burns. Global issues such as fire accidents and burns have a major impact on growth of dermal grafts market over the forecast period. Market is mainly driven by increasing adoption of the dermal grafts globally due to increasing socioeconomic status. Development of health care accessibility and infrastructure expected to fuel the hospital end user segment in the global skin grafts market. Market players globally adopting innovation in grafting technologies to increase their market share. In addition, acquisitions, mergers are key strategies adopted by market players. For instance, in August 2016, Mallinckrodt plc., a leading speciality pharmaceutical company, acquired Stratatech Corporation, a privately held regenerative medicine company focused on the development of unique, proprietary skin substitute products, such as stratagrafs regenerative skin tissue and a technology platform for genetically enhanced skin tissues. Similarly, in 2014, Organogenesis Inc., a commercial leader in the field of regenerative medicine has acquired the Dermagraft assets (human fibroblast-derived dermal substitute) from Shire plc.

Geographically, dermal grafts market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the significant market share owing to favourable reimbursement policies and higher healthcare expenditure. Adaptation of new technologies and increased skin related diseases are boosting the North America dermal grafts market. Europe dermal grafts market driven by large disposable income and rising awareness of newer technologies in dermal grafting among key stakeholders. Asia Pacific region is projected to have the fastest growth and is expected to lead by growing economies such as India and China. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to show minimal growth rate due to poor healthcare infrastructure and market penetration.

Some of the players in dermal grafts market include Organogenesis, Inc. (U.S.), Stratatech Corp. (U.S), Avita Medical (U.K.), ConvaTec Group plc. (U.K.), Coloplast (Denmark), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany), Medtronic (Stratatech Corporation) (U.S.), Zimmer Biomet. (U.S.), Nouvag AG (Switzerland), Tissue Regenix Group PLC (U.K), and Allergan Plc (Ireland)

In February 2017, Allergan plc, acquired LifeCell Corporation, a leading regenerative medicine company. LifeCell Corporation portfolio include, alloderm, a human allograft tissue matrix used in breast reconstruction post-mastectomy, and revolve, a single use high-volume fat grafting device used in plastic and reconstructive procedures. Additionally, LifeCell markets strattice, porcine based tissue matrix used in complex abdominal wall repair and for the surgical repair of damaged or ruptured soft tissue.

In January 2016, Integra LifeSciences Corporation’s omnigraft dermal regeneration matrix received new indication from the U.S. Food and Drug Administration (U.S. FDA) to treat certain diabetic foot ulcers

REPORT OUTLINE:
  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY

2. GLOBAL DERMAL GRAFTS MARKET INTRODUCTION

2.1. Global Dermal Grafts Market– Taxonomy
2.2. Global Dermal Grafts Market–Definitions
  2.2.1. Equipment Type
  2.2.2. Application

3. GLOBAL DERMAL GRAFTS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dermal Grafts Market Dynamics – Factors Impact Analysis
3.6. Global Dermal Grafts Market– Recent Market Introductions

4. GLOBAL DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY EQUIPMENT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Knives Dermatomes
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Electric Dermatomes
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. General Surgical Instruments
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Consumables
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Air Dermatomes
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis

6. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY GRAFT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Autologous
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Isogenic
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Allogeneic
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Xenogeneic
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Prosthetic
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY THICKNESS, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Split Thickness
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Full Thickness
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Composite Graft
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Burns
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Extensive Wound
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Skin Cancer
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Infection
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Others
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis

9. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Hospitals
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Dermatology Clinics
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Ambulatory Surgical Centers
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis

10. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. North America
  10.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  10.1.3. Market Opportunity Analysis
10.2. Europe
  10.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
  10.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  10.3.3. Market Opportunity Analysis
10.4. Latin America
  10.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
  10.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  10.5.3. Market Opportunity Analysis
10.6. Global Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Region, 2017 – 2023

11. NORTH AMERICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.1.1. Knives Dermatomes
    11.1.1.2. Electric Dermatomes
    11.1.1.3. General Surgical Instruments
    11.1.1.4. Consumables
    11.1.1.5. Air Dermatomes
  11.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Autologous
    11.1.2.2. Isogenic
    11.1.2.3. Allogeneic
    11.1.2.4. Xenogeneic
    11.1.2.5. Prosthetic
  11.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Split Thickness
    11.1.3.2. Full Thickness
    11.1.3.3. Composite Graft
  11.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Burns
    11.1.4.2. Extensive Wound
    11.1.4.3. Skin Cancer
    11.1.4.4. Infection
    11.1.4.5. Others
  11.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Hospitals
    11.1.5.2. Dermatology Clinics
    11.1.5.3. Ambulatory Surgical Centers
  11.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    11.1.6.1. U.S.
    11.1.6.2. Canada
  11.1.7. North America Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
  11.1.8. North America Dermal Grafts Market Dynamics – Trends

12. EUROPE DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.1.1. Knives Dermatomes
    12.1.1.2. Electric Dermatomes
    12.1.1.3. General Surgical Instruments
    12.1.1.4. Consumables
    12.1.1.5. Air Dermatomes
  12.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Autologous
    12.1.2.2. Isogenic
    12.1.2.3. Allogeneic
    12.1.2.4. Xenogeneic
    12.1.2.5. Prosthetic
  12.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Split Thickness
    12.1.3.2. Full Thickness
    12.1.3.3. Composite Graft
  12.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Burns
    12.1.4.2. Extensive Wound
    12.1.4.3. Skin Cancer
    12.1.4.4. Infection
    12.1.4.5. Others
  12.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.5.1. Hospitals
    12.1.5.2. Dermatology Clinics
    12.1.5.3. Ambulatory Surgical Centers
  12.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.6.1. Germany
    12.1.6.2. UK
    12.1.6.3. France
    12.1.6.4. Spain
    12.1.6.5. Italy
    12.1.6.6. Russia
    12.1.6.7. Poland
    12.1.6.8. Rest of Europe
  12.1.7. Europe Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
  12.1.8. Europe Dermal Grafts Market Dynamics – Trends

13. ASIA-PACIFIC DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.1.1. Knives Dermatomes
    13.1.1.2. Electric Dermatomes
    13.1.1.3. General Surgical Instruments
    13.1.1.4. Consumables
    13.1.1.5. Air Dermatomes
  13.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Autologous
    13.1.2.2. Isogenic
    13.1.2.3. Allogeneic
    13.1.2.4. Xenogeneic
    13.1.2.5. Prosthetic
  13.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Split Thickness
    13.1.3.2. Full Thickness
    13.1.3.3. Composite Graft
  13.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Burns
    13.1.4.2. Extensive Wound
    13.1.4.3. Skin Cancer
    13.1.4.4. Infection
    13.1.4.5. Others
  13.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Hospitals
    13.1.5.2. Dermatology Clinics
    13.1.5.3. Ambulatory Surgical Centers
  13.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    13.1.6.1. Japan
    13.1.6.2. China
    13.1.6.3. India
    13.1.6.4. ASEAN
    13.1.6.5. Australia & New Zealand
    13.1.6.6. Rest of Asia-Pacific
  13.1.7. Asia-Pacific Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
  13.1.8. Asia-Pacific Dermal Grafts Market Dynamics – Trends

14. LATIN AMERICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.1.1. Knives Dermatomes
    14.1.1.2. Electric Dermatomes
    14.1.1.3. General Surgical Instruments
    14.1.1.4. Consumables
    14.1.1.5. Air Dermatomes
  14.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Autologous
    14.1.2.2. Isogenic
    14.1.2.3. Allogeneic
    14.1.2.4. Xenogeneic
    14.1.2.5. Prosthetic
  14.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Split Thickness
    14.1.3.2. Full Thickness
    14.1.3.3. Composite Graft
  14.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Burns
    14.1.4.2. Extensive Wound
    14.1.4.3. Skin Cancer
    14.1.4.4. Infection
    14.1.4.5. Others
  14.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.5.1. Hospitals
    14.1.5.2. Dermatology Clinics
    14.1.5.3. Ambulatory Surgical Centers
  14.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.6.1. Brazil
    14.1.6.2. Mexico
    14.1.6.3. Argentina
    14.1.6.4. Venezuela
    14.1.6.5. Rest of Latin America
  14.1.7. Latin America Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
  14.1.8. Latin America Dermal Grafts Market Dynamics – Trends

15. MIDDLE EAST & AFRICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  15.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    15.1.1.1. Knives Dermatomes
    15.1.1.2. Electric Dermatomes
    15.1.1.3. General Surgical Instruments
    15.1.1.4. Consumables
    15.1.1.5. Air Dermatomes
  15.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    15.1.2.1. Autologous
    15.1.2.2. Isogenic
    15.1.2.3. Allogeneic
    15.1.2.4. Xenogeneic
    15.1.2.5. Prosthetic
  15.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    15.1.3.1. Split Thickness
    15.1.3.2. Full Thickness
    15.1.3.3. Composite Graft
  15.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    15.1.4.1. Burns
    15.1.4.2. Extensive Wound
    15.1.4.3. Skin Cancer
    15.1.4.4. Infection
    15.1.4.5. Others
  15.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    15.1.5.1. Hospitals
    15.1.5.2. Dermatology Clinics
    15.1.5.3. Ambulatory Surgical Centers
  15.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    15.1.6.1. Gulf Cooperation Council (GCC) Countries
    15.1.6.2. Israel
    15.1.6.3. South Africa
    15.1.6.4. Rest of MEA
  15.1.7. MEA Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
  15.1.8. MEA Dermal Grafts Market Dynamics – Trends

16. COMPETITION LANDSCAPE

16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  16.2.1. Organogenesis, Inc. (U.S.)
  16.2.2. Stratatech Corp. (U.S)
  16.2.3. Avita Medical (U.K.)
  16.2.4. ConvaTec Group plc. (U.K.)
  16.2.5. Coloplast (Denmark)
  16.2.6. B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany)
  16.2.7. Medtronic (Stratatech Corporation) (U.S.)
  16.2.8. Zimmer Biomet. (U.S.)
  16.2.9. Nouvag AG (Switzerland)
  16.2.10. Tissue Regenix Group PLC (U.K)
  16.2.11. Allergan Plc (Ireland)

17. RESEARCH METHODOLOGY

18. KEY ASSUMPTIONS AND ACRONYMS


More Publications